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Objective
To analyze the characteristics and outcome of acute
Hepatitis C and the risk of reinfection following SVR in
HIV+ MSM.
Methods
Database analysis of the ICH cohort (n=4851), analysis
restricted to MSM seen between 1/2002 and 6/2010.
Acute HCV infection was defined as a sudden rise in
liver enzymes with a positive HCV PCR and/or a newly
positive HCV serology (if negative before). The probabil-
ity of reinfection was analyzed from primary diagnosis
or end of HCV treatment until reinfection or last f/u
(last blood sample).
Results
99 episodes of acute Hepatitis C (aHCV) were identified
in 88 MSM since 2002. Case numbers increased since
2006, with no association with ART treatment status,
HIV viral load or CD4 count. 42% had GT1a/b, 1% GT
2, 17% GT3, and 26% GT4. SVR was achieved in 45
(74%) of those 61 patients observed for more than 6
months after diagnosis or the end of HCV therapy
either spontaneously (n=13) or after treatment with
pegIFN/RBV (n=32). Reinfections occurred in 10 of
these cases (11%), 3x with the same GT, 7x with a dif-
ferent GT (1x 1->3, 4x 3->1, 1x 4->1, 1x 1->4); reinfec-
tion was observed after spontaneous clearance in 4 and
after treatment-induced clearance in 6 cases. 1 patient
exhibited spontaneous clearance of two GT1a reinfec-
tions and an initial GT3 infection. In those achieving
SVR, the cumulative probability of becoming reinfected
after primary diagnosis or the end of HCV therapy,
respectively, was 45% within six years (Kaplan-Meier).
Within the time-frame of the analysis, only three cases
of aHCV were observed in our STD clinic population in
HIV-negative MSM (all GT4).
Conclusions
Acute hepatitis C is an increasing problem in HIV+
MSM. The distribution of genotypes indicates an epi-
demic separate from the general population. Despite a
high overall rate of spontaneous or treatment-induced
SVR, patients are at high risk of reinfection with the
same GT or others. These observations strongly support
the EACS guidelines with regard to routine HCV testing
and evaluation of LFT abnormalities. All HIV+ MSM,
but especially subjects with previous aHCV should
receive intensive and repeated counseling in order to
reduce transmission risks.
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